<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02435537</url>
  </required_header>
  <id_info>
    <org_study_id>IORG0006563/reference. no. 64</org_study_id>
    <nct_id>NCT02435537</nct_id>
  </id_info>
  <brief_title>Combined Intrathecal Morphine and Dexmedetomidine Analgesia</brief_title>
  <acronym>ITMandDEX</acronym>
  <official_title>Safety and Efficacy of Dexmedetomidine Addition to Intrathecal Morphine for Postoperative Analgesia in Cancer Patients Undergoing Major Abdominal Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The current study investigated the effect of adding dexmedetomidine to intrathecal morphine
      for postoperative analgesia in cancer patients undergoing major abdominal surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Opioids, administered intrathecal or epidural, are widely used for postoperative, and chronic
      nociceptive pain secondary to cancers. Intrathecal injection of morphine to provide
      postoperative analgesia during the initial 24 h after operation is a widely used
      technique.The Human studies on the antinociceptive effects of co-administrated intrathecal
      morphine and dexmedetomidine in postoperative pain are still lacking. In this study, the
      investigators aimed to compare the synergistic interaction and side-effects of combined
      intrathecal morphine and dexmedetomidine with either drug alone for postoperative analgesia
      in cancer patients undergoing major abdominal surgery. Patients were randomly allocated into
      three groups of 30 patients each to receive either; hyperbaric bupivacaine 0.5% (Group
      I/Bupivacaine Group), bupivacaine and 0.5 mg morphine (Group II/Morphine Group), bupivacaine
      and 0.5 mg morphine plus 5 µg of dexmedetomidine (Group III/Morphine-DEX Group). The assigned
      drugs were dissolved in 1ml physiological saline and administered intrathecal with
      bupivacaine before induction of general anesthesia.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Actual">March 2015</completion_date>
  <primary_completion_date type="Actual">March 2015</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>total dose of intravenous PCA morphine consumption in the first 48 h postoperative</measure>
    <time_frame>48 hours</time_frame>
    <description>Calculating the cumulative intravenous PCA morphine dose</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Noninvasive blood pressure</measure>
    <time_frame>48 hours</time_frame>
    <description>non invasive systolic and diastolic blood pressure intra-operative and postoperative in the 6th, 12th, 18th, 24th, 36th, and 48th h postoperative.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>48 hours</time_frame>
    <description>non invasive assessment of heart rate in the 6th, 12th, 18th, 24th, 36th, and 48th postoperative. intraoperative and postoperative</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>peripheral arterial oxygen saturation</measure>
    <time_frame>48 hours</time_frame>
    <description>assessment of pulse oximetry intraoperative and in the 6th, 12th, 18th, 24th, 36th, and 48th h postoperative</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative VAS scores</measure>
    <time_frame>48 hours</time_frame>
    <description>assessment of pain scores on admission to surgical intensive care unit and in the 6th, 12th, 18th, 24th, 36th, and 48th h postoperative.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time to first request for analgesia</measure>
    <time_frame>48hours</time_frame>
    <description>measuring the time in hours of first request for intravenous PCA morphine</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Intrathecal Bupivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>intrathecal injection of 10 mg hyperbaric bupivacaine 0.5% in 2 ml volume and 1ml of saline 0.9%</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intrathecal Morphine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>intrathecal injection of 10mg bupivacaine 0.5% in 2ml volume intrathecal injection of 0.5 mg morphine in 1ml volume</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intrathecal Morphine-Dex</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>intrathecal 10mg bupivacaine 0.5% in 2 ml volume intrathecal 0.5 mg morphine intrathecal 5 µg of dexmedetomidine in 1ml volume .</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine (Precedex)</intervention_name>
    <description>intrathecal administration</description>
    <arm_group_label>Intrathecal Morphine-Dex</arm_group_label>
    <other_name>Precedex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>intrathecal 10 mg bupivacaine</description>
    <arm_group_label>Intrathecal Bupivacaine</arm_group_label>
    <arm_group_label>Intrathecal Morphine</arm_group_label>
    <arm_group_label>Intrathecal Morphine-Dex</arm_group_label>
    <other_name>Buvicaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine</intervention_name>
    <description>intrathecal 0.5mg morphine</description>
    <arm_group_label>Intrathecal Morphine</arm_group_label>
    <arm_group_label>Intrathecal Morphine-Dex</arm_group_label>
    <other_name>morphine sulphate</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - major abdominal cancer surgery (e.g. hemi-colectomy or cystectomy)

        Exclusion Criteria:

          -  known allergy to study drugs

          -  Significant cardiac, respiratory, renal or hepatic disease.

          -  2nd or 3rd degree heart block.

          -  Coagulation disorders.

          -  Low back pain or other back problems.

          -  Drug or alcohol abuse.

          -  BMI&gt;30kg\m2.

          -  Psychiatric illnesses that would interfere with perception and assessment of pain.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Saher AB Mohamed, MD</last_name>
    <role>Study Director</role>
    <affiliation>Assisstant professor in Anesthesia and intensive care department, South Egypt Cancer institute, Assiut university, Egypt</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hala s Abdel-Ghaffar, MD</last_name>
    <role>Study Director</role>
    <affiliation>Assisstant professor in Anesthesia and intensive care department, faculty of medicine, Assiut university, Egypt.</affiliation>
  </overall_official>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 26, 2015</study_first_submitted>
  <study_first_submitted_qc>May 5, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 6, 2015</study_first_posted>
  <last_update_submitted>May 5, 2015</last_update_submitted>
  <last_update_submitted_qc>May 5, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 6, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Khaled Mohamed Fares</investigator_full_name>
    <investigator_title>Professor in Anesthesia and intensive care department, South Egypt Cancer institute, Assiut university, Egypt.</investigator_title>
  </responsible_party>
  <keyword>analgesia</keyword>
  <keyword>intrathecal</keyword>
  <keyword>opioids</keyword>
  <keyword>morphine</keyword>
  <keyword>dexmedetomidine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

